OTCMKTS:CRLBF Cresco Labs Q3 2025 Earnings Results & Report $0.64 -0.01 (-0.79%) As of 03:59 PM Eastern Cresco Labs missed analyst earnings expectations but beat on revenue in its Q3 2025 results, released November 7, 2025. The company reported EPS of -$0.05 versus the -$0.03 consensus estimate, while revenue of $165.00 million topped the $163.74 million estimate by $1.26 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2025Report DateNovember 7, 2025TimeBefore Market Opens Cresco Labs EPS ResultsActual EPS-$0.05Consensus EPS -$0.03Beat/MissMissed by -$0.02One Year Ago EPSN/AEPS Beat Rate1 of last 8 quartersCresco Labs Revenue ResultsActual Revenue$165.00 millionExpected Revenue$163.74 millionBeat/MissBeat by +$1.26 millionYoY Revenue GrowthN/AUpcoming EarningsCresco Labs' next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Cresco Labs Q3 2025 Earnings FAQ Did Cresco Labs beat earnings estimates for Q3 2025? Cresco Labs (OTCMKTS:CRLBF) reported earnings of -$0.05 per share for Q3 2025, missing the consensus estimate of -$0.03. The report was announced on Friday, November 7, 2025. What was Cresco Labs' revenue for Q3 2025? Cresco Labs reported revenue of $165.00 million for Q3 2025, against a consensus estimate of $163.74 million. When is Cresco Labs' next earnings date? Cresco Labs' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Cresco Labs on the company's earnings history page. Cresco Labs Earnings HeadlinesCresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special MeetingOctober 9 at 5:10 PM | financialpost.comFCresco Labs (OTCMKTS:CRLBF) Stock Rating Upgraded by Zacks ResearchOctober 8, 2026 | americanbankingnews.comMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a contest offering its biggest holders a seat at dinner with the President. It's also about 97% below its peak. Because a memecoin doesn't benefit from good policy. It benefits from attention. The real winners of a pro-crypto Washington are the projects with actual businesses underneath them. Ones that get more valuable as rules get clearer, institutions get comfortable, and more money flows into the market.October 12 at 1:00 AM | Crypto 101 Media (Ad)Cresco Labs Announces Filing of Management Information Circular for Annual General and Special MeetingSeptember 24, 2026 | financialpost.comFCresco Labs Announces Filing of Management Information Circular for Annual General and Special MeetingSeptember 24, 2026 | businesswire.comCresco Labs Inc. (CL:CA): Analysts Forecast Big Upside For StockSeptember 21, 2026 | theglobeandmail.comSee More Cresco Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cresco Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cresco Labs and other key companies, straight to your email. Email Address About Cresco LabsCresco Labs (OTCMKTS:CRLBF) is a vertically integrated cannabis company headquartered in Chicago, Illinois. Founded in 2013, the company cultivates, manufactures and distributes cannabis products for adult-use and medical markets in states where cannabis is legally permitted. The company’s product portfolio includes flower, pre-rolls, vapes, concentrates, edibles and other cannabis products sold under brands such as Cresco, High Supply, Good News, Wonder Wellness, FloraCal, Remedi and Mindy’s Edibles. Cresco Labs also operates Sunnyside dispensaries, which sell cannabis products directly to consumers. Cresco Labs serves multiple U.S. cannabis markets, including Illinois and other states with regulated adult-use or medical programs. Its operations generally span cultivation facilities, processing and manufacturing sites, wholesale distribution and retail dispensaries, allowing the company to participate in several stages of the cannabis supply chain.View Cresco Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 5 Retail Picks to Watch as the Holiday Shopping Season NearsMarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsC.H. Robinson Bets Its AI Story on RXO—But the Market Isn't SoldApplied Digital’s Hidden Moat Could Unlock Massive Upside Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
